BIRMINGHAM, Ala.–(BUSINESS WIRE)–Guideway Care, a national leader in advancing health equity by resolving patient barriers related to social determinants of health (SDoH), optimizing patient outcomes and lowering total costs in Value-Based Care, announces its has been awarded a national group purchasing agreement for a patient engagement solution with Premier, Inc. Effective September 1, 2022, the … [Read more…]
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, November 1, 2022. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Third Quarter … [Read more…]
New investments in testing infrastructure will enable Lifespin to analyze up to 300,000 patient samples annually to support its metabolic profiling services BOSTON–(BUSINESS WIRE)–Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, announced today that it has installed additional Nuclear Magnetic Resonance (NMR) equipment which will double Lifespin’s annual laboratory testing capacity. Lifespin … [Read more…]
LAS VEGAS–(BUSINESS WIRE)–Kent Spafford, a well-known executive and leader in the workers’ compensation sector for three decades, is joining Harvard MedTech as a special advisor to the CEO, Shan Padda. “Harvard MedTech is bringing the most creative and powerful solution to alleviating pain and trauma that we have seen in more than a generation,” noted … [Read more…]
Findings support deep learning ex vivo drug screening with patient tissue as a promising tool to identify effective, individual treatments in advanced blood cancer over conventional methods Custom deep learning algorithms and single-cell analysis of >1 billion patient cells reveals further potential for improved patient outcomes VIENNA & OXFORD, England–(BUSINESS WIRE)–Exscientia (Nasdaq: EXAI), ETH Zurich, … [Read more…]
– AB-201 is a novel and highly specific HER2-directed cell therapy candidate developed using Artiva’s proprietary CAR technology and scaled AlloNK™ manufacturing platform – Clinical evaluation of AB-201 in HER2-positive cancers is planned to initiate in 1H2023 SAN DIEGO–(BUSINESS WIRE)–#CARNK—Artiva Biotherapeutics, Inc., a clinical stage company whose mission is to deliver highly effective, off-the-shelf, allogeneic … [Read more…]
ATLANTA–(BUSINESS WIRE)–The healthcare research firm KLAS has named Vatica Health to its 2022 Emerging Solutions Top 20 list, which recognizes innovative companies that have the greatest potential to impact and disrupt the healthcare market. Vatica, the leader in prospective, PCP-centric risk adjustment and clinical quality solutions, is the only risk adjustment solution to earn a … [Read more…]
Atrium Health Recently Participated in Semperis’ $200M+ Funding Round, Led by KKR HOBOKEN, N.J.–(BUSINESS WIRE)–Semperis, a pioneer of identity-driven cyber resilience for enterprises, today announced the addition of Todd Greene, Vice President & Enterprise CISO at Charlotte, North Carolina-based Atrium Health, to its Strategic Advisory Board. Atrium Health participated in Semperis’ recent Series C funding … [Read more…]
Anzu Partners led the $14M financing round with participation from Amgen Ventures and EDBI ImmunoScape’s Deep Immunomics and machine learning platforms comprise a highly effective method for the discovery of T-cell receptor (TCR) candidates, targeting novel antigens such as cancer-specific shared splice variants and human endogenous retroviral elements The company is poised to take a … [Read more…]
GLY-200 is a First-in-Class, Oral, Gut-Targeted Approach for Treatment of Type 2 Diabetes and Related Metabolic Conditions Newly Released Phase 1 Biomarker Data is Consistent with Effects of Roux-en-Y Gastric Bypass Surgery and Duodenal Exclusion Devices Initial Data from Phase 2 Trial Evaluating GLY-200 in Patients with Type 2 Diabetes Anticipated in Early 2023 BOSTON–(BUSINESS … [Read more…]
